Consumer Health: Treating Esophageal Cancer

This content is courtesy of Mayo Clinic, the No. 1 hospital in the nation according to U.S. News & World Report. Minnesota Oncology is a member of the Mayo Clinic Care Network. This relationship provides us with access to information, knowledge and expertise from Mayo Clinic.

 

April is Esophageal Cancer Awareness Month, which makes this a good time to learn more about treating esophageal cancer, the sixth most common cause of cancer deaths worldwide.

Esophageal cancer is more common among men than women, and it can occur anywhere along the esophagus. Signs and symptoms of esophageal cancer include difficulty swallowing, unexplained weight loss, heartburn, coughing, hoarseness, and chest pain or pressure. Risk factors include smoking, drinking alcohol, being obese, and not eating enough fruits and vegetables.

If you've been diagnosed with esophageal cancer, your treatment will be based on the type of cells involved in your cancer, the stage of your cancer, and your overall health and preferences. Treatment can include surgery, chemotherapy, radiation therapy, targeted drug therapy or immunotherapy.

Learn more about the options for treating esophageal cancer.

Share

Categories

Tags

Recent Posts

#
March 21, 2024

We know the importance of safeguarding your data and are committed to maintaining the highest standards of privacy and security. Change Healthcare reports that their privacy office and information security teams are working to understand the impact to patients. At this time, we have not received any notices that your personal or medical data has been compromised because of this outage.

#
March 20, 2024

March is Myeloma Awareness Month. Myeloma begins when a plasma cell becomes abnormal. The abnormal cell divides to make copies of itself. The new cells divide again and again, making more and more abnormal cells. These abnormal plasma cells are called myeloma cells.

#
March 19, 2024

Approximately 81,600 new cases of kidney cancer ― more than 52,000 in men and 29,000 in women ― will be diagnosed in the U.S. this year, and 14,390 people ― 9,450 men and 4,940 women ― will die from the disease, according to the American Cancer Society.